Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR ...
Introduction Ovarian cancer is one of the most lethal gynecological diseases, with a five-year survival rate of only 30%.1 Developing biomarkers for early diagnosis and treatment of ovarian cancer is considered important to overcome ovarian cancer …